COPD activates bitter taste receptors, the target of asthma treatment

Published Date: 17 Mar 2023

Germany: Activation of bitter taste receptors opens lung pathways, making them potential targets for the treatment of chronic lung diseases...

Read Full News

Latest News

PAP Therapy May Reduce Pulmonary Pressures in Sleep Apnea

Positive airway pressure therapy is linked with reduced pulmonary arterial pressures in patients with severe obstructive sleep apnea or obesity hypoventilation syndrome.

Amazon to Stock Lilly's New Weight-loss Pill At US Kiosks, Offer Same-day Delivery

Amazon.com said on Thursday its pharmacy unit will stock Eli Lilly's new weight-loss pill at kiosks located at some of the company's ⁠primary care clinics and offer same-day...

Treprostinil Can Slow Lung Decline in Pulmonary Fibrosis

Inhaled treprostinil may slow the decline in lung function and reduce the risk for disease worsening in patients with idiopathic pulmonary fibrosis.

Can Past Sleep Problems Hinder Smoking Cessation?

People with existing sleep problems may find it harder to quit smoking when seeking help to stop using tobacco.

Fan-to-Face Therapy May Ease Breathlessness in Lung Disease

Adding fan-to-face therapy to a supervised exercise training program lowers exertional breathlessness across training sessions and improves training tolerability in patients with chronic lung disease.

Preterm BPD May Reduce Exercise Capacity at School Age

School-aged children born prematurely with bronchopulmonary dysplasia may have exercise-related limitations compared with healthy term-born peers.

Todays Updates

Early Tislelizumab May Boost PFS in Esophageal Cancer

For patients with locally advanced esophageal cancer, front-loading immunotherapy with induction chemo and chemoradiotherapy, without maintenance immunotherapy, may improve outcomes.

ctDNA Predicts Relapse in Locally Advanced Cervical Cancer

Posttreatment ctDNA positivity correlates with worse relapse-free survival and earlier recurrence in patients with locally advanced cervical cancer, real-world data show.

GLP-1 RAs May Lower Hysterectomy Risk in Endometrial Cancer

There’s now a hint that GLP-1 receptor agonists might prevent hysterectomies in endometrial intraepithelial neoplasia/early-stage endometrial cancer, but prospective trials are needed to confirm it.

Todays Updates

Early Tislelizumab May Boost PFS in Esophageal Cancer

For patients with locally advanced esophageal cancer, front-loading immunotherapy with induction chemo and chemoradiotherapy, without maintenance immunotherapy, may improve outcomes.

ctDNA Predicts Relapse in Locally Advanced Cervical Cancer

Posttreatment ctDNA positivity correlates with worse relapse-free survival and earlier recurrence in patients with locally advanced cervical cancer, real-world data show.

GLP-1 RAs May Lower Hysterectomy Risk in Endometrial Cancer

There’s now a hint that GLP-1 receptor agonists might prevent hysterectomies in endometrial intraepithelial neoplasia/early-stage endometrial cancer, but prospective trials are needed to confirm it.

Latest News

Positive airway pressure therapy is linked with reduced pulmonary arterial pressures in patients with severe obstructive sleep apnea or obesity hypoventilation syndrome.

Amazon.com said on Thursday its pharmacy unit will stock Eli Lilly's new weight-loss pill at kiosks located at some of the company's ⁠primary care clinics and offer same-day...

Inhaled treprostinil may slow the decline in lung function and reduce the risk for disease worsening in patients with idiopathic pulmonary fibrosis.

People with existing sleep problems may find it harder to quit smoking when seeking help to stop using tobacco.

Adding fan-to-face therapy to a supervised exercise training program lowers exertional breathlessness across training sessions and improves training tolerability in patients with chronic lung disease.

School-aged children born prematurely with bronchopulmonary dysplasia may have exercise-related limitations compared with healthy term-born peers.

News All Time

New CHEST Recommendations Guide Biologic Use for Severe Asthma

New CHEST Recommendations Guide Biologic Use for Severe Asthma

FDA Clears LEADOPTIK's LIA System for Higher-Accuracy Lung Biopsy

FDA Clears LEADOPTIK's LIA System for Higher-Accuracy Lung Biopsy

Stopping Inhaled Corticosteroids or LAMA in COPD Linked to Early Exacerbations

Stopping Inhaled Corticosteroids or LAMA in COPD Linked to Early Exacerbations

From GOLD to Ground Level: Navigating Biologic Use in COPD Care

From GOLD to Ground Level: Navigating Biologic Use in COPD Care

Bronchodilator Response Outperforms Genetic Risk in Predicting COPD Progression

Bronchodilator Response Outperforms Genetic Risk in Predicting COPD Progression

Additional Phase 2 REVERT IPF Data Shows Greater Fibrosis Reduction With TTI-101

Additional Phase 2 REVERT IPF Data Shows Greater Fibrosis Reduction With TTI-101

5 Pulmonology Headlines You Missed in December 2025

5 Pulmonology Headlines You Missed in December 2025

Q4 2025 Recap: Pulmonology News and Updates

Q4 2025 Recap: Pulmonology News and Updates

Pulmonology in 2025: Year in Review

Pulmonology in 2025: Year in Review

Asthma in 2025: Year in Review

Asthma in 2025: Year in Review

COPD in 2025: Year in Review

COPD in 2025: Year in Review

Characterizing COPD - Lung Cancer Patients, with Joseph Friedberg, MD Joseph Friedberg, MD, Kevin Kunzmann

Friedberg discusses the inconsistent clinical pathways from disease progression to intervention in patients with a pair of highly deadly lung diseases.

Post-NICU PM2.5 Exposure Raises Asthma Risk in Children With Bronchopulmonary Dysplasia

Post-NICU PM2.5 Exposure Raises Asthma Risk in Children With Bronchopulmonary Dysplasia

Asthma Biologic Adherence Shaped by Psychological, Clinical, Systemic Factors

Asthma Biologic Adherence Shaped by Psychological, Clinical, Systemic Factors

FDA Approves Nerandomilast (Jascayd) Tablets for Progressive Pulmonary Fibrosis

FDA Approves Nerandomilast (Jascayd) Tablets for Progressive Pulmonary Fibrosis

FDA Approves Depemokimab-ulaa (Exdensur) for Severe Asthma

FDA Approves Depemokimab-ulaa (Exdensur) for Severe Asthma

Recommended News For You

EBV Screening Tied to Lower Nasopharyngeal Cancer Mortality Risk

One-third of childhood cancer survivors experience significant fear that it could come back, study reveals

In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.

Cancer during young adulthood carries long-term mental toll, study finds

Metastatic Cancer 'Thrivers'; Celebrity Cancer Diagnoses; 'Would He Have Lived?'

Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC

Report: High risk of lung cancer from respirable crystalline silica even below the current occupational exposure limit

Recommended Articles For You

Demystifying Hypereosinophilic Syndrome: Symptoms, Diagnosis, and Treatment Options  

Understanding Axitinib: What You Need To Know For Your Treatment Plan 

Breakthroughs in Cancer Care: From Rare Diagnoses to Advanced and Early-Stage Treatments 

The Statistical Evolution of Cancer Staging and Its Precision Impact on Prognosis and Therapy in Cancer Staging 2025 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Charles III, King of Kings, is Cancerous.

2.

Adopted cancer cells and the effects of their presence.

3.

Clinical trial results show low-intensity therapy can achieve positive outcomes for certain pediatric leukemia subtypes

4.

Knowing about and avoiding bladder cancer.

5.

New drug combination shows good results in patients with HPV-negative head and neck cancer

1.

Apheresis vs. IVMP in Cancer Treatment: A Tale of Two Titans

2.

Optimizing Chemotherapy Dosing: From Phase 1 Dose Escalation to Modification

3.

The Truth About Marijuana and Its Effect on Mental Health 

4.

Sorafenib: Understanding the science behind a powerful cancer drug 

5.

The Transformative Power of Genomics in the Diagnosis and Management of Rare Cancers

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2

2.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion

3.

Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals

4.

Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary

5.

Navigating the Complexities of Ph Negative ALL - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot